We are live on ! Find out more
EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

120 hedge funds and large institutions have $1.08B invested in Eagle Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

520% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 10

121% more capital invested

Capital invested by funds: $489M → $1.08B (+$592M)

76% more funds holding

Funds holding: 68 → 120 (+52)

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

12% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 26

75% less call options, than puts

Call options by funds: $1.36M | Put options by funds: $5.5M

Holders
120
Holders Change
+52
Holders Change %
+76.47%
% of All Funds
3.23%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
62
Increased
29
Reduced
26
Closed
10
Calls
$1.36M
Puts
$5.5M
Net Calls
-$4.14M
Net Calls Change
-$4.14M

Top Buyers

Rank Fund Capital Flow
1
RIM
Ranger Investment Management
Texas
+$29.7M
2
CCM
Consonance Capital Management
New York
+$29.1M
3
State Street
State Street
Massachusetts
+$28.1M
4
PA
Perceptive Advisors
New York
+$14.4M
5
BFA
BlackRock Fund Advisors
California
+$12.8M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$27.1M
2
GE
General Electric
Ohio
-$25.2M
3
Morgan Stanley
Morgan Stanley
New York
-$11.2M
4
PWAM
Park West Asset Management
California
-$7.9M
5
EI
EAM Investors
California
-$5.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
51
Panagora Asset Management
Massachusetts
$1.8M +$662K +10,164 +84%
CAM
52
ClariVest Asset Management
California
$1.66M +$776K +11,917 +139%
Deutsche Bank
53
Deutsche Bank
Germany
$1.66M +$1.33M +20,484 New
Ameriprise
54
Ameriprise
Minnesota
$1.54M +$22.6K +347 +2%
GAM
55
Gotham Asset Management
New York
$1.53M +$1.23M +18,945 New
Goldman Sachs
56
Goldman Sachs
New York
$1.46M +$538K +8,259 +84%
NFA
57
Nationwide Fund Advisors
Ohio
$1.31M +$1.05M +16,164 New
AllianceBernstein
58
AllianceBernstein
Tennessee
$1.27M +$1.02M +15,700 New
California State Teachers Retirement System (CalSTRS)
59
California State Teachers Retirement System (CalSTRS)
California
$1.27M +$1.02M +15,670 New
RSS
60
Rosenblum Silverman Sutton
California
$1.13M +$908K +13,940 New
Susquehanna International Group
61
Susquehanna International Group
Pennsylvania
$1.05M -$1.09M -16,764 -56%
TA
62
Teachers Advisors
New York
$1.01M +$815K +12,515 New
Charles Schwab
63
Charles Schwab
California
$1M +$809K +12,424 New
CS
64
Credit Suisse
Switzerland
$908K -$205K -3,149 -22%
Millennium Management
65
Millennium Management
New York
$902K -$1.5M -23,097 -67%
Two Sigma Advisers
66
Two Sigma Advisers
New York
$881K +$710K +10,900 New
California Public Employees Retirement System
67
California Public Employees Retirement System
California
$809K +$651K +10,000 New
SO
68
STRS Ohio
Ohio
$792K +$638K +9,800 New
Swiss National Bank
69
Swiss National Bank
Switzerland
$768K +$619K +9,500 New
QIM
70
Quantitative Investment Management
Virginia
$743K +$599K +9,200 New
BG
71
BlackRock Group
United Kingdom
$739K +$595K +9,139 New
PNC Financial Services Group
72
PNC Financial Services Group
Pennsylvania
$735K +$592K +9,086 New
New York State Common Retirement Fund
73
New York State Common Retirement Fund
New York
$720K +$397K +6,093 +217%
AL
74
Airain Ltd
Guernsey
$717K +$62.9K +966 +12%
Voloridge Investment Management
75
Voloridge Investment Management
Florida
$701K +$565K +8,674 New
1 2
3
4 5

EGRX Hedge Fund Activity: Q2 2015 in Review

120 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Eagle Pharmaceuticals, Inc. (EGRX) for Q2 2015, worth a combined $1.08B — up 121% from $489M a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new EGRX positions and 10 closed out — a net gain of 52 holders — while 29 added to existing stakes and 26 trimmed.

The largest buyer was Ranger Investment Management, opening a new position worth an estimated $29.7M. The largest seller was Cormorant Asset Management, cutting an estimated $27.1M.

  • 120 institutional investors held Eagle Pharmaceuticals, Inc. (EGRX) as of Q2 2015, up from 68 in Q1 2015.
  • Funds reported $1.08B of Eagle Pharmaceuticals, Inc. stock for Q2 2015, up 121% quarter-over-quarter.
  • 62 funds opened new Eagle Pharmaceuticals, Inc. positions in Q2 2015 and 10 closed out, a net change of +52 holders.
  • The largest Eagle Pharmaceuticals, Inc. buyer in Q2 2015 was Ranger Investment Management, an estimated $29.7M added.
  • The largest Eagle Pharmaceuticals, Inc. seller in Q2 2015 was Cormorant Asset Management, an estimated $27.1M sold.

Based on aggregated 13F filings for Q2 2015.